Ultrasound Guidance in Paravertebral Injections of Oxygen-Ozone: Treatment of Low Back Pain
|Araimo Morselli FSM*, Zuccarini F, Scarpa I, Imperiale C, Guzzo F, Toro F and Tordiglione P|
|Department of Anaesthesiology and Critical Care Medicine, Sapienza University of Rome, Italy|
|Corresponding Author :||Fabio Silvio Mario Araimo Morselli
Department of Anaesthesiology and Critical Care Medicine
Sapienza University of Rome
Viale del Policlinico 155, 00186, Rome, Italy
Tel: +39 333 508 3507
Fax: +39 06 499 791 91
E-mail: [email protected]
|Received: September 09, 2015 Accepted: December 02, 2015 Published: December 08, 2015|
|Citation: Araimo Morselli FSM, Zuccarini F, Scarpa I, Imperiale C, Guzzo F, et al. (2015) Ultrasound Guidance in Paravertebral Injections of Oxygen-Ozone: Treatment of Low Back Pain. J Pain Relief 4:220. doi:10.4172/2187-0846.1000220|
|Copyright: © 2015 Araimo Morselli FSM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at Pubmed, Scholar Google|
Background: Paravertebral injection of ozone is an established clinical practice for the treatment of Low Back Pain (LBP). The role of Ultrasound Guidance (USG) in mini invasive procedures has become important in many clinical practice thanks to the greater precision this technique can add. As matter of fact, a large volume of ozone in a single administration may have some adverse or side effects. In this study we wanted to verify if the use of USG in Oxygen/ Ozone (O2/O3) infiltrations could allow the administration of a smaller volume of gas mixture, increasing the safety and the comfort of the procedure itself, obtaining however similar or better results in pain decrease.
Methods: We compared two groups of 25 patients affected by LBP, undergoing 10 infiltrations of O2/O3, by using USG (group U) or only anatomical landmarks (group AL). Pain intensity, by calculating Visual Analogical Scale (VAS) difference before and after the treatment, and the discomfort were evaluated in both groups.
Results: The mean of the VAS before the treatment was 6.44 in group U and 6.48 in group AL. The mean of the VAS after the treatment was 2.22 in group U and 3.04 in group AL. The mean of discomfort rate was 2.84 in group U and 5.44 in group AL. The number of patients with unbearable discomfort was 0 in group U and 7 in group AL.
Conclusions: As many other treatment, also paravertebral injections of O2/O3 benefits of the advantages of the US device which makes this treatment safer and more accurate.